FindTrial
Sign In

Evaluation of the effectiveness and safety of various optical methods for myopia control: A multicenter rea world study

Evaluation of the effectiveness and safety of various optical methods for myopia control: A multicenter real world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073356
Enrollment
Unknown
Registered
2023-07-07
Start date
2023-07-07
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

DIMS group:N/A
AURA group:N/A
HAL group:N/A
OK group:N/A

Sponsors

Changsha Aier Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 16 Years

Inclusion criteria

Inclusion criteria: Age: 6-16 years old No gender limitation Cycloplegic refraction: binocular spherical power=+1.50D, astigmatism = 2.00D Informed consent from parents and subjects was obtained

Exclusion criteria

Exclusion criteria: Amblyopia, strabismus and other organic eye diseases Unable to complete the relevant examinations Follow up period less than 12 months Any other myopia control means, such as low dose atropine or repeated low-intensity red light therapy, were used within 6 months prior to inclusion or during follow-up.

Design outcomes

Primary

MeasureTime frame
Axial length;Cycloplegic spherical equivalent refraction;—

Countries

China

Contacts

Public ContactLongbo Wen

Hunan Aier institute of optometry and vision science

15111486614@163.com+86 133 1956 1293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026